Latest Competition News

Immutep Limited has confirmed 30 mg as the optimal biological dose for its immunotherapy efti, following FDA approval of Project Optimus requirements. This milestone paves the way for the US launch of its pivotal Phase III lung cancer trial.

Legacy Minerals has partnered with Rio Tinto in a farm-in deal that could see up to $25 million invested in exploring the vast Thomson Project in NSW for intrusion-related copper and gold deposits.

Nimy Resources reminds shareholders of the imminent closing of its Share Purchase Plan, following promising developments at its Mons Critical Mineral project and a recent $1.72 million placement.

SSH Group has reported a robust 17% increase in revenue for the September quarter, underscoring strong operational performance at its Mt Fisher Gold Project.

St Barbara Limited has successfully raised A$58 million through an institutional placement to fund key growth initiatives at its Simberi gold operations, signaling confidence in its expansion strategy.

Wildcat Resources has completed a key tenement swap with Northern Star Pilbara, acquiring a crucial licence adjacent to its Tabba Tabba lithium project. This move is set to enhance the project's development and cost structure ahead of the 2026 feasibility study.

Australian Gold and Copper Ltd has reported exceptional new drilling results at its Achilles deposit, extending high-grade silver and gold mineralisation down plunge by 50 metres. These findings bolster the upcoming maiden Mineral Resource Estimate and highlight the deposit’s significant growth potential.

Fletcher Building reports a decline in sales volumes and margin pressures in Q1 FY26, driven by weak demand and intense competition in New Zealand. The company launches a NZ$100 million cost-out program to navigate ongoing market challenges.

MAC Copper Limited’s shares will be suspended from trading following court approval of its acquisition by Harmony Gold, marking a significant shift in ownership for the copper miner.

Hydrix Limited will have its trading suspension lifted on 13 October 2025 following the release of its audited financial statements for FY2025. Investors await clarity on the company’s financial health as it returns to the ASX.

NSX Limited shareholders have overwhelmingly approved a scheme of arrangement for acquisition by a CNSX Markets-related entity, setting the stage for a significant market transition pending court approval.

Delorean Corporation has received a $2.7 million milestone payment from ARENA, advancing its SA1 Salisbury bioenergy facility toward renewable gas production underpinned by a key offtake deal with Origin Energy.